Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,250.80
-142.20 (-5.94%)
May 22, 2026, 3:30 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 637.52 billion as of May 22, 2026. Its market cap has increased by 60.63% in one year.
Market Cap
637.52B
Enterprise Value
622.86B
Revenue
165.10B
Ranking
n/a
PE Ratio
59.86
Stock Price
2,250.80
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 637.52B, an increase of 55,370.12%. That is a compound annual growth rate of 28.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 637.52B | 11.00% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.13T |
| Zydus Lifesciences | 1.04T |
| Mankind Pharma | 1.04T |
| Aurobindo Pharma | 898.33B |
| Laurus Labs | 729.35B |
| Alkem Laboratories | 657.79B |
| Ipca Laboratories | 415.31B |
| Ajanta Pharma | 393.30B |